ETV Bharat / bharat
Exclusive | 39 Critical And 325 Major Deficiencies Found In Sresan Pharmaceutical Manufacturer Facility In Tamil Nadu During Joint Inspection
During the joint inspection of the facility, 39 critical and 325 major deviations were identified, exposing significant non-compliance with Good Manufacturing Practices
Chennai: During a joint inspection by drug inspectors on October 3 conducted at Ms. Sresan Pharmaceutical Manufacturer in Kanchipuram District, Tamil Nadu, a large number of non-compliances were revealed. The company manufactured the Coldrif cough syrup (Chloropheniramine Maleate Syrup) linked to at least 22 children’s deaths in Madhya Pradesh. The inspection report recorded a total of 364 deviations, including 39 critical and 325 major deficiencies.